Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia

Wenjia Lv1, Mengzhu Cao1, Jingju Liu1

  • 1Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education, National & Local United Engineering Laboratory for Power Batteries, Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Analysis and Testing Center, Department of Chemistry, Northeast Normal University, Changchun, Jilin Province 130024, China.

Acta Biomaterialia
|August 18, 2021
PubMed

Insights

This study developed a novel nanozyme system that generates reactive oxygen species (ROS) to combat tumors. The system overcomes tumor hypoxia and glutathione defenses, enhancing cancer treatment efficacy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Reactive oxygen species (ROS)-mediated antitumor therapies show promise due to low toxicity and high specificity.
  • Clinical efficacy is limited by the tumor microenvironment (TME), particularly hypoxia and glutathione (GSH) antioxidant effects.

Purpose of the Study:

  • To design a multinanozyme system to overcome TME limitations for enhanced cancer therapy.
  • To develop a system with ROS generation, oxygen self-evolution, GSH depletion, and hyperthermia capabilities.

Main Methods:

  • Constructed hyaluronic acid (HA)-stabilized CuMnOx nanoparticles (CMOH) loaded with indocyanine green (ICG).
  • Investigated CMOH nanozymes' peroxidase-like and oxidase-like activities in acidic TME.
  • Evaluated CMOI NCs' singlet oxygen generation, hyperthermia effect, catalase-like activity, and GSH consumption.

Main Results:

  • CMOH nanozymes efficiently generated ROS (•OH, •O2−) in acidic TME.
  • CMOI NCs produced singlet oxygen (1O2) and hyperthermia under light irradiation, enhancing ROS generation.
  • CMOI NCs relieved tumor hypoxia by producing O2 and consumed GSH, boosting ROS-based therapy.

Conclusions:

  • HA-modified CMOI NCs demonstrated synergistic photothermal therapy (PTT)-enhanced oxidation therapy.
  • The developed nanozyme system effectively overcomes tumor hypoxia and high antioxidant defense.
  • This work provides a high-performance therapeutic reagent for advanced cancer treatment.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
773
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K